Bon Natural Life Ltd (BON) stock

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30

$1.10−0.03 (-2.65%)

Close on Nov 13, 2026Market cap $8.94MP/E –Yield –

Bon Natural Life EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Bon Natural Life's EV/EBITDA was 3.0× on Nov 28, 2025, against 24.1× a year earlier. Over the last 3 years it ranged from 3.0× to 802.6×, with a median of 24.1×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2025	Nov 28, 2025	3.0×	−58.2
2024	Dec 31, 2024	61.3×	+37.6
2023	Dec 29, 2023	23.6×	−302.7
2022	Dec 30, 2022	326.3×	–

Where these numbers come from

Parsed from the XBRL in Bon Natural Life's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-25 reverse split on May 19, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BON.

Compare: BON vs HYEX · BON vs CYAN · BON vs MDWD · BON vs SNYRQ · BON vs BGM

Revenue growth-21.7% · median 8.5%

Gross margin20.8% · median 61.1%

Operating margin-8.7% · median -21.9%

Net margin-10.7% · median -14.0%

Company	Revenue	Growth
SNYRQ	$27.70M	-17.5%
CYAN	$25.27M	+8.5%
BON	$18.67M	-21.7%
HYEX	$6.29M	+84.1%
MDWD	–	–
BGM	–	–

Company

Exchange: Nasdaq
Industry: Medicinal Chemicals & Botanical Products
Fiscal year ends: September 30
Employees: 96
Auditor: YCM CPA INC
SEC CIK: 1816815

Advertisement
300 × 250

See a number that looks wrong?

Bon Natural Life EV/EBITDA

EV/EBITDA at the end of each year

More Bon Natural Life figures